Stocksigma LogoStocksigma Logo

Lord’s Mark Industries Secures UK MHRA Registration for In Vitro Diagnostics Portfolio

Lord’s Mark Industries Limited received UK MHRA registration on 24th Sep'26 for its in vitro diagnostics (IVD) portfolio, covering haematological cell

Lord’s Mark Industries Secures UK MHRA Registration for In Vitro Diagnostics Portfolio

Lords Mark Industries Ltd · Others (Uncategorized) · 05 Oct 2026, 2:10 pm

Lord’s Mark Industries Secures UK MHRA Registration for In Vitro Diagnostics Portfolio Lord’s Mark Industries Limited received UK MHRA registration on 24th Sep'26 for its in vitro diagnostics (IVD) portfolio, covering haematological cell analysers, clinical chemistry analysers, buffered diluents, and cleaning agents. Commercial sales in the UK are slated to begin in Dec'26, two months ahead of schedule, with further expansion targeted across UK-allied markets. Additionally, the company plans to commence UK pathology laboratory operations in Jan'27, transitioning toward an integrated healthcare delivery model following its recent registration of the AI-powered Renalyx haemodialysis system.

Original exchange filing (PDF)

More announcements from Lords Mark Industries Ltd

All Lords Mark Industries Ltd announcements